Tadalafil Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 2.5 mg, 5 mg, 10 mg, 20 mg and 40 mg(P. Hypertension)
Reference Brands: Cialis(US & EU),Adcirca(US)
Category:
Sexual Wellness
Tadalafil inhibits phosphodiesterase type 5 (PDE5), increasing nitric oxide effects and blood flow to the penis, aiding erectile function. It also relaxes prostate muscles, relieving BPH symptoms. Benefits include rapid onset, long duration (up to 36 hours), convenience, and improved sexual performance and quality of life for men with ED or BPH.
Tadalafil tablets is available in Tablet
and strengths such as 2.5 mg, 5 mg, 10 mg, 20 mg and 40 mg(P. Hypertension).
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Tadalafil tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Tadalafil tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Tadalafil tablets, marketed as Cialis, are approved in the US by the FDA and in the EU via EMA for erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical trial and manufacturing data, while the EMA ensures compliance with regional safety and quality standards.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing